Rkman, D., Likić, R., Bebek, M., Gnjidić, M. & Gamulin, M. (2019). Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report. Croatian Medical Journal, 60. (6), 552-555. doi: 10.3325/cmj.2019.60.552
Rkman, Deni, et al. "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report." Croatian Medical Journal, vol. 60, no. 6, 2019, pp. 552-555. https://doi.org/10.3325/cmj.2019.60.552
Rkman, Deni, Robert Likić, Marko Bebek, Milena Gnjidić and Marija Gamulin. "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report." Croatian Medical Journal 60, no. 6 (2019): 552-555. https://doi.org/10.3325/cmj.2019.60.552
Rkman, D., et al. (2019) 'Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report', Croatian Medical Journal, 60(6), pp. 552-555. doi: 10.3325/cmj.2019.60.552
Rkman D, Likić R, Bebek M, Gnjidić M, Gamulin M. Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report. Croatian Medical Journal [Internet]. 2019 [cited 2024 November 10];60(6):552-555. doi: 10.3325/cmj.2019.60.552
D. Rkman, R. Likić, M. Bebek, M. Gnjidić and M. Gamulin, "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report", Croatian Medical Journal, vol. 60, no. 6, pp. 552-555, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:676034. [Accessed: 10 November 2024]
